Companies / ganlee-pharmaceutical

Ganlee Pharmaceutical

ChinaIndustrial & Manufacturing

Overview

Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro mix 75/25 injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, a mixed protamine human insulin injection. The c

Employees5309
Market Cap$32.1B
Revenue$3.9B
Listed OnShanghai Stock Exchange
Ticker603087
CEOMr. Zhongru Gan Ph.D.
HeadquartersBeijing

Website

https://www.ganlee.com